India Glycols

Bio-EO and MEG — Green surfactants and textiles.

Country: India
Ticker: INDIAGLYCO.NS

bio-eo in legacy

Coverage

	CN	EU	IN	US
platform-chemicals	✓	✓	✓	✓

Regulatorsepareachmoa-china

Verifiable facts

Fact	Value	Source
Funding	₹ 467 Cr (preferential allotment of 51,03,765 equity shares)	indiaglycols.com
Capacity	600 KLPD (Kashipur) and 500 KLPD (Gorakhpur) for ethanol; 200,000 MTPA for MEG (historical capacity)	indiaglycols.com
Certification	ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 50001:2018, SA 8000:2014, FSSC 22000, ISO 22000:2018	bseindia.com · indiaglycols.com · lifecycleinitiative.org
Regulatory approval	DSIR-approved R&D center, US FDA approval (plant-specific)	bseindia.com · indiaglycols.com
Production site	Kashipur, Gorakhpur, and Dehradun	bseindia.com · indiaglycols.com
Headcount	1,357 employees (as of March 31, 2025); 3,951 total workforce (1,283 employees and 2,668 workers in FY 2025-26) medium confidence	finance.yahoo.com · investoomarket.com · stockanalysis.com
Revenue	₹ 1,203 Cr (FY26 consolidated revenue); ₹ 4,920 Cr (consolidated sales for FY 2025-26)	bseindia.com · indiaglycols.com

Independent sources: bseindia.com · finance.yahoo.com · investoomarket.com · lifecycleinitiative.org · stockanalysis.com

Technologies

Name	Cluster	Risk
Biosynthetic ethylene & bio-ethylene oxide	platform-chemicals	Low	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.